Get the Stockscreener App
0.00
100.00%
-4.02
After Hours:
4.01
4.01
+
Nanovibronix Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
See More
Previous Close:
$4.02
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$4.37M
Revenue:
$3.29M
Net Income/Loss:
$-3.09M
P/E Ratio:
0.00
EPS:
-1.23
Net Cash Flow:
$-2.46M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$161.00
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.00 | 4.37M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
112.21 | 195.08B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
380.23 | 142.61B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
96.86 | 125.10B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
74.58 | 112.29B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
79.78 | 45.80B | 6.07B | 1.06B | 799.60M | 1.8527 |
Nanovibronix Inc Stock (NAOV) Latest News
Is NanoVibronix Inc. stock a defensive play in 2025Weekly Investment Recap & High Accuracy Swing Trade Signals - mfd.ru
Head-To-Head Review: Nanovibronix (FEED) versus The Competition - Defense World
Analyzing Nanovibronix (FEED) & Its Competitors - Defense World
Nanovibronix (FEED) & Its Competitors Financial Comparison - Defense World
Analyst Upgrade: Is NanoVibronix Inc a potential multi baggerWeekly Trading Summary & Real-Time Price Movement Reports - baoquankhu1.vn
Fundamentals Check: Is McCormick Company Incorporated gaining market share2025 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn
Nanovibronix (FEED) & Its Competitors Head to Head Review - Defense World
Head to Head Analysis: Nanovibronix (FEED) vs. Its Competitors - Defense World
Contrasting Nanovibronix (NASDAQ:FEED) and Biosig Technologies (NASDAQ:STEX) - Defense World
Financial Survey: TransEnterix (OTCMKTS:TRXDW) versus Nanovibronix (NASDAQ:FEED) - Defense World
Is NanoVibronix Inc. stock affected by interest rate hikesAnalyst Upgrade & Verified Technical Signals - mfd.ru
Will NanoVibronix Inc. (56R) stock profit from fiscal stimulus2025 Price Momentum & Weekly Stock Breakout Alerts - mfd.ru
Can NanoVibronix Inc. generate free cash flow2025 Risk Factors & High Accuracy Swing Trade Signals - mfd.ru
Is NanoVibronix Inc. a potential multi bagger2025 Key Lessons & Real-Time Buy Signal Notifications - mfd.ru
Will NanoVibronix Inc. be affected by tariffs2025 Top Decliners & Real-Time Price Movement Reports - mfd.ru
Is NanoVibronix Inc. stock overvalued by current metricsLong Setup & Short-Term Trading Opportunity Alerts - mfd.ru
Is NanoVibronix Inc. subject to activist investor interest2025 Earnings Impact & Advanced Swing Trade Entry Alerts - mfd.ru
Targets Report: What are the future prospects of Arlo Technologies Inc2025 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
MACD Signal: What makes NanoVibronix Inc stock attractive todayAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Envue Medical: Bank of America sells $8.9k in stock By Investing.com - Investing.com UK
Envue Medical: Bank of America sells $8.9k in stock - Investing.com
Top Small Cap Stocks To Keep An Eye OnJanuary 29th - MarketBeat
Manufacturing Stocks To ResearchJanuary 29th - MarketBeat
Stop Loss: Is ACCS trading at a discount2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
ENvue Medical skyrockets on reusable feeding tube syringe distribution deal - Mugglehead Investment Magazine
ENvue Medical partners with U-Deliver to distribute ENFit syringes By Investing.com - Investing.com Nigeria
Why Is FEED Stock Soaring Over 130% Today? - Asianet Newsable
ENvue Medical Appoints New VP to Boost Enteral Platform Expansion - StocksToTrade
ENvue Medical partners with U-Deliver to distribute ENFit syringes - Investing.com
EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal - Benzinga
Targets Report: Is Groupon Inc in a bullish channel2025 Investor Takeaways & AI Forecast Swing Trade Picks - baoquankhu1.vn
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial - Sahm
IPO Launch: Is NanoVibronix Inc a potential multi baggerJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
Targets Report: How does SGMO perform in inflationary periods2025 Top Decliners & Target Return Focused Picks - baoquankhu1.vn
Aug Update: Can OXYWS disrupt its industryJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Market Pulse: Is NanoVibronix Inc stock showing strong momentum2025 Sector Review & Daily Stock Trend Reports - baoquankhu1.vn
Can NanoVibronix Inc. stock sustain revenue growth2025 Risk Factors & Breakout Confirmation Trade Signals - Улправда
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research - The Manila Times
ENvue Medical Launches Program to Address Patient Pain and - GlobeNewswire
New program targets pain from nasogastric tubes left in for days - Stock Titan
Why NanoVibronix Inc. stock is seen as undervaluedJuly 2025 Momentum & AI Based Buy and Sell Signals - Улправда
Why NanoVibronix Inc. stock could outperform in 2025July 2025 Recap & Trade Opportunity Analysis Reports - Улправда
Is NanoVibronix Inc. (56R) stock a top pick for value investors2025 Performance Recap & Free Community Consensus Stock Picks - ulpravda.ru
Can NanoVibronix Inc. (56R) stock deliver strong annual returns2025 Short Interest & Community Verified Watchlist Alerts - Улправда
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 - GlobeNewswire
How analysts revise price targets for NanoVibronix Inc. (56R) stockJuly 2025 Levels & Fast Entry and Exit Trade Plans - Улправда
Will NanoVibronix Inc. (56R) stock beat international competitionHigh Beta Stocks & Invest Now – Opportunity Window Closing - Улправда
Envue Medical amends long term incentive plan to align with Israeli tax laws - Investing.com
ENvue Medical, Inc.Common Stock (NQ: NAOV - FinancialContent
Short Covering: Will NanoVibronix Inc stock continue dividend increases2025 Winners & Losers & High Conviction Buy Zone Alerts - moha.gov.vn
Market Outlook: Is CANF stock a top momentum playTrade Exit Summary & Daily Chart Pattern Signals - moha.gov.vn
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
1.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):